Filing Details
- Accession Number:
- 0001415889-23-004317
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-06 16:30:34
- Reporting Period:
- 2023-03-02
- Accepted Time:
- 2023-03-06 16:30:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-02 | 8,000 | $113.08 | 8,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-02 | 451 | $241.97 | 7,679 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-02 | 1,045 | $242.72 | 6,634 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-02 | 937 | $244.09 | 5,697 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-02 | 3,887 | $244.85 | 1,810 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-02 | 1,680 | $245.71 | 130 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-03-03 | 8,000 | $113.08 | 8,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-03 | 625 | $244.00 | 7,505 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-03 | 636 | $244.94 | 6,869 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-03 | 450 | $246.12 | 6,419 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-03 | 1,961 | $246.95 | 4,458 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-03 | 2,418 | $248.32 | 2,040 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-03 | 1,910 | $248.83 | 130 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2023-03-02 | 8,000 | $0.00 | 8,000 | $113.08 |
| Common Stock | Stock Options | Disposition | 2023-03-03 | 8,000 | $0.00 | 8,000 | $113.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 336,000 | 2013-12-31 | 2023-12-31 | No | 4 | M | Direct |
| 328,000 | 2013-12-31 | 2023-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 166 | Indirect | By Spouse |
| Common Stock | 644,183 | Indirect | By Trusts |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.
- This transaction was executed in multiple trades at prices ranging from $241.275 to $242.265. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $242.275 to $243.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $243.36 to $244.355. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $244.38 to $245.375. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $245.39 to $246.285. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $243.395 to $244.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $244.465 to $245.355. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $245.54 to $246.495. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $246.60 to $247.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $247.61 to $248.595. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $248.635 to $249.165. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
